137 related articles for article (PubMed ID: 935859)
1. Isolations of a cartilage factor that inhibits tumor neovascularization.
Langer R; Brem H; Falterman K; Klein M; Folkman J
Science; 1976 Jul; 193(4247):70-2. PubMed ID: 935859
[TBL] [Abstract][Full Text] [Related]
2. Vitreous inhibition of tumor neovascularization.
Felton SM; Brown GC; Felberg NT; Federman JL
Arch Ophthalmol; 1979 Sep; 97(9):1710-3. PubMed ID: 475643
[TBL] [Abstract][Full Text] [Related]
3. Control of tumor growth in animals by infusion of an angiogenesis inhibitor.
Langer R; Conn H; Vacanti J; Haudenschild C; Folkman J
Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4331-5. PubMed ID: 6159628
[TBL] [Abstract][Full Text] [Related]
4. A novel angiogenic inhibitor derived from Japanese shark cartilage (I). Extraction and estimation of inhibitory activities toward tumor and embryonic angiogenesis.
Oikawa T; Ashino-Fuse H; Shimamura M; Koide U; Iwaguchi T
Cancer Lett; 1990 Jun; 51(3):181-6. PubMed ID: 1693543
[TBL] [Abstract][Full Text] [Related]
5. Proteinase inhibitors of bovine nasal cartilage.
Roughley PJ; Murphy G; Barrett AJ
Biochem J; 1978 Mar; 169(3):721-4. PubMed ID: 646796
[TBL] [Abstract][Full Text] [Related]
6. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis.
Ausprunk DH; Folkman J
Microvasc Res; 1977 Jul; 14(1):53-65. PubMed ID: 895546
[No Abstract] [Full Text] [Related]
7. Inhibition of tumor angiogenesis mediated by cartilage.
Brem H; Folkman J
J Exp Med; 1975 Feb; 141(2):427-39. PubMed ID: 1113064
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
[TBL] [Abstract][Full Text] [Related]
9. Shark cartilage contains inhibitors of tumor angiogenesis.
Lee A; Langer R
Science; 1983 Sep; 221(4616):1185-7. PubMed ID: 6193581
[TBL] [Abstract][Full Text] [Related]
10. Purification of a bifunctional amylase/protease inhibitor from ragi (Eleusine coracana) by chromatography and its use as an affinity ligand.
Saxena L; Iyer BK; Ananthanarayan L
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(19):1549-54. PubMed ID: 20444654
[TBL] [Abstract][Full Text] [Related]
11. Prolonged tumor dormancy by prevention of neovascularization in the vitreous.
Brem S; Brem H; Folkman J; Finkelstein D; Patz A
Cancer Res; 1976 Aug; 36(8):2807-12. PubMed ID: 1277191
[TBL] [Abstract][Full Text] [Related]
12. Relation of vascular proliferation to tumor growth.
Folkman J; Cotran R
Int Rev Exp Pathol; 1976; 16():207-48. PubMed ID: 783062
[No Abstract] [Full Text] [Related]
13. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
Vajkoczy P; Farhadi M; Gaumann A; Heidenreich R; Erber R; Wunder A; Tonn JC; Menger MD; Breier G
J Clin Invest; 2002 Mar; 109(6):777-85. PubMed ID: 11901186
[TBL] [Abstract][Full Text] [Related]
14. A vertebrate interstitial collagenase inhibitor from bovine scapular cartilage: purification and characterization.
Gabrielides C; Barreau F
Biochim Biophys Acta; 1987 Apr; 924(1):238-47. PubMed ID: 3030445
[TBL] [Abstract][Full Text] [Related]
15. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
[TBL] [Abstract][Full Text] [Related]
16. Identification of an inhibitor of neovascularization from cartilage.
Moses MA; Sudhalter J; Langer R
Science; 1990 Jun; 248(4961):1408-10. PubMed ID: 1694043
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses.
Sidky YA; Borden EC
Cancer Res; 1987 Oct; 47(19):5155-61. PubMed ID: 2441862
[TBL] [Abstract][Full Text] [Related]
18. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
Prewett M; Huber J; Li Y; Santiago A; O'Connor W; King K; Overholser J; Hooper A; Pytowski B; Witte L; Bohlen P; Hicklin DJ
Cancer Res; 1999 Oct; 59(20):5209-18. PubMed ID: 10537299
[TBL] [Abstract][Full Text] [Related]
19. Correlation of antiangiogenic and antitumor efficacy of N-biphenyl sulfonyl-phenylalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitor.
Maekawa R; Maki H; Yoshida H; Hojo K; Tanaka H; Wada T; Uchida N; Takeda Y; Kasai H; Okamoto H; Tsuzuki H; Kambayashi Y; Watanabe F; Kawada K; Toda K; Ohtani M; Sugita K; Yoshioka T
Cancer Res; 1999 Mar; 59(6):1231-5. PubMed ID: 10096553
[TBL] [Abstract][Full Text] [Related]
20. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
